EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The Involvement of CSRP1 in Neuroblastoma Differentiation and Apoptosis Impacting Tumor‐Suppressive Therapeutic Responses

Yu-Han Lin iD, Jyun-Hong Jiang, Hui-Ching Chuang, Chao-Cheng Huang, Wen-Ming Hsu, Min-Tsui Wu, Ting-Ya Chen, Wei-Shiung Lian iD, Jiin-Haur Chuang

The FASEB Journal · 15.04.2025 · 39 (7)

DOI: 10.1096/fj.202500403r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 08.04.2025. Verfasst von Yu-Han Lin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Mitochondrial Research and Medicine, College of Medicine Chang Gung University, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Neuroblastoma, Apoptosis, Cell Differentiation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Science and Technology Council (NSTC), Chang Gung Medical Foundation | Kaohsiung Chang Gung Memorial Hospital (Kaohsiung CGMH), Kaohsiung Chang Gung Memorial Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroblastoma (NB) is a pediatric malignancy from the neural crest, where differentiation plays a key role in prognosis. We investigated cysteine and glycine‐rich protein 1 (CSRP1) as a therapeutic target for NB, as it has been linked to differentiation and carcinogenesis in various cancers. Immunohistochemical analysis of archived NB samples showed a significant correlation between CSRP1 expression and differentiation. Ectopic CSRP1 expression in MYCN ‐amplified BE(2)‐M17 cells increased sensitivity to cisplatin, promoted neurite extension, and enhanced differentiation, apoptosis, and chemosensitivity to 13cisRA. Synergistic apoptotic effects were observed with 5‐aza‐2′‐deoxycytidine (DAC) and Poly(I:C) treatments in SK‐N‐AS cells implanted in xenografts, linked to upregulation of CSRP1, innate immune receptor RIG‐I, and caspase‐9 activation. CSRP1 expression was significantly higher in mitochondrial DNA‐depleted SK‐N‐AS ρ 0 cells, compared to parent SK‐N‐AS cells. Cisplatin increased CSRP1 expression further in parent cells but not in ρ 0 cells. Simultaneous upregulation of caspase‐8 was found in both cell types, but increased caspase‐9 only in parent cells, suggesting that both intrinsic and extrinsic apoptosis pathways are involved in CSRP1 function depending on the existence of mitochondrial DNA. These findings indicate that CSRP1 is involved in differentiation, determination of apoptosis, and possibly innate immunity in NB, which endows CSRP1 with the potential to enhance the effects of 13cisRA, DAC, and Poly(I:C) in combination therapies for NB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuroblastomaApoptosisCell DifferentiationHumansAnimalsCell Line, TumorMiceCisplatinDecitabinePoly I-CAntineoplastic AgentsGene Expression Regulation, NeoplasticMice, Nude

Stichwörter der Autor:innen

CSRP1CSRP1‐targeted therapiesapoptosismitochondrial integrityneuroblastomaxenograft

Substanzen

CisplatinDecitabinePoly I-CAntineoplastic Agents

Autor:innen und Institutionen

  • Center for Mitochondrial Research and Medicine, College of Medicine Chang Gung University, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
  • Department of Pediatric Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
  • Department of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
  • Department of Pathology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
  • Department of Surgery, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Core Laboratory for Phenomics & Diagnostics, Department of Medical Research, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University, Kaohsiung, Taiwan.

ORCID-Profile: Yu-Han Lin, Wei-Shiung Lian

Förderung

  • National Science and Technology Council (NSTC)
  • Chang Gung Medical Foundation | Kaohsiung Chang Gung Memorial Hospital (Kaohsiung CGMH)
  • Kaohsiung Chang Gung Memorial Hospital

Zitieren

APA

Lin, Y. H., Jiang, J. H., Chuang, H. C., Huang, C. C., Hsu, W. M., Wu, M. T., Chen, T. Y., Lian, W. S., & Chuang, J. H. (2025). The Involvement of CSRP1 in Neuroblastoma Differentiation and Apoptosis Impacting Tumor‐Suppressive Therapeutic Responses. The FASEB Journal, 39(7). https://doi.org/10.1096/fj.202500403r

Vancouver

Lin YH, Jiang JH, Chuang HC, Huang CC, Hsu WM, Wu MT, et al. The Involvement of CSRP1 in Neuroblastoma Differentiation and Apoptosis Impacting Tumor‐Suppressive Therapeutic Responses. The FASEB Journal. 2025;39(7). doi:10.1096/fj.202500403r

BibTeX
@article{Lin2025,
  author = {Lin, Yu-Han and Jiang, Jyun-Hong and Chuang, Hui-Ching and Huang, Chao-Cheng and Hsu, Wen-Ming and Wu, Min-Tsui and Chen, Ting-Ya and Lian, Wei-Shiung and Chuang, Jiin-Haur},
  title = {The Involvement of CSRP1 in Neuroblastoma Differentiation and Apoptosis Impacting Tumor‐Suppressive Therapeutic Responses},
  journal = {The FASEB Journal},
  year = {2025},
  volume = {39},
  number = {7},
  doi = {10.1096/fj.202500403r}
}
Kostenlos starten →